Safety and efficacy of three enteral feeding strategies in patients with severe stroke in China (OPENS): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
Jingjing Zhao,Fang Yuan,Changgeng Song,Rong Yin,Mingze Chang,Wei Zhang,Bei Zhang,Liping Yu,Yi Jia,Yaling Ma,Yongbin Song,Chengkai Wang,Chaohui Song,Xinlai Wang,Lei Shang,Fang Yang,Wen Jiang,OPENS Trial Investigators,Lili Sun,Yuanfang Zhao,Jiangya Wei,Lijuan Liu,Mengmeng Hu,Xuan Wang,Jingjing Zhang,Xiaodan Shi,Bo Hui,Rong Chen,Xianhui Ren,Fang Du,Yaxuan Wei,Yuanming Li,Mingze Chang Chang,Xiujuan Zhang,Yanling Yin,Jun Guo,Peng Guo,Jiarui Lu,Chuan Li,Jinjin Shen,Miao Bai,Min Zhang,Shijun Zhang,Yulan Bai,Yanan Bai,Wenjun Fan,Lin Wang,Fangfang Yu,Yanni Ru,Wei Wei,Wenzong Wang,Ruoruo Hu,Yajuan Li,Xuemei Ma,Tao Lv,Hao Zhu,Linsong Yang,Yaxin Wu,Junxia Cao,Tao Wu,Hongxing Zhang,Saibing Liu,Bo Ning,Hongyan Zhao,Zhongyi Li,Haiyan Zhang,Mingming Wang,Yong Zhu,Siwen Chen,Qianmeng Ren,Shuang Lu,Qiufeng You,Zhiqin Liu,Yi Jiang,Jing Xiong,Xiaocheng Wang,Rong Zhao,Kang Huo,Chen Chen,Yongcai Qu,Li Ma,Xiai Yang,Yi Liu,Xingsheng Wang
DOI: https://doi.org/10.1016/S1474-4422(22)00010-2
Abstract:Background: Early enteral nutrition is crucial for preventing malnutrition and improving outcomes in patients with severe stroke, but previous trials have provided conflicting results regarding the optimal nutritional strategy. We aimed to compare the efficacy and safety of three enteral feeding strategies in patients with severe stroke. Methods: The Optimizing Early Enteral Nutrition in Severe Stroke (OPENS) study was a multicentre, investigator-initiated, prospective, open-label, randomised controlled trial, with blinded outcome assessment, in 16 tertiary and district general hospitals in the west of China. Adult patients with acute severe ischaemic or haemorrhagic stroke (Glasgow Coma Scale score ≤12 or National Institutes of Health Stroke Scale score ≥11 on admission) who were expected to receive enteral nutrition for more than 7 days were randomly assigned (1:1:1) to full enteral nutrition (70-100% of estimated caloric requirements), modified full enteral nutrition (full enteral nutrition plus prokinetic agents), or hypocaloric enteral nutrition (40-60% of estimated caloric requirements) via a centralised web-based randomisation system. The assigned nutrition was initiated within 24 h after enrolment and continued for 7 days. The computer-generated randomisation sequence was prepared by a statistician not involved with the rest of the study. Randomisation was done with an automated permuted block size of six. The allocation was unblinded to participants and investigators. The primary efficacy outcome was the proportion of participants with poor outcome (modified Rankin Scale score ≥3) at day 90 and the prespecified primary safety outcome was mortality at day 90, assessed in the intention-to-treat population. The trial is registered with ClinicalTrials.gov, NCT02982668. Findings: Between Jan 15, 2017, and Sept 23, 2020, 321 patients were randomly assigned (107 in each group) and 315 patients (175 [56%] men, median age 71 years, IQR 60-78) were included in the final analysis. The study was terminated ahead of schedule on Sept 23, 2020, because a significant difference between groups was detected in mortality. The proportion of participants with poor outcomes at 90 days did not differ (modified full enteral nutrition 86 [82%] of 105 patients vs full enteral nutrition 85 [80%] of 106 patients, adjusted odds ratio [OR] 0·87, 95% CI 0·41-1·86, p=0·721; hypocaloric enteral nutrition 76 [73%] of 104 patients vs full enteral nutrition 0·61, 0·30-1·27, p=0·186; hypocaloric enteral nutrition vs modified full enteral nutrition 0·70, 0·34-1·46, p=0·340). Hypocaloric enteral nutrition showed significantly higher 90-day mortality than did modified full enteral nutrition (35 [34%] of 104 patients vs 18 [17%] of 105 patients, adjusted OR 2·89, 95% CI 1·46-5·72; p=0·0023), whereas the difference was not significant between hypocaloric enteral nutrition and full enteral nutrition (24 [23%] of 106 patients; adjusted OR 1·92, 95% CI 1·00-3·69; p=0·049), and between modified full enteral nutrition and full enteral nutrition (adjusted OR 0·61, 0·29-1·28; p=0·187). The most common adverse event was pneumonia, the incidence of which showed no significant difference among groups (full enteral nutrition 82 [78%] of 105 patients, modified full enteral nutrition 83 [81%] of 103 patients, hypocaloric enteral nutrition 78 [75%] of 104 patients; p=0·625). Interpretation: In the early phase of severe stroke, modified full enteral nutrition or hypocaloric enteral nutrition did not significantly reduce the risk of a poor outcomes compared with full enteral nutrition over a 90-day period. Hypocaloric enteral nutrition might be associated with increased mortality compared with modified full enteral nutrition. Further studies are needed to investigate whether modified full enteral nutrition might be the optimal strategy. Funding: Shaanxi province Key Research and Development Project.